GETI-B:STO
Getinge publ AB
SEKÂ 249.70
arrow_upward
+1.34%(+3.30) 1D
Oct 5, 12:24:01 PM GMT+2 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GETI-B...
Open
SEKÂ 246.40
High
SEKÂ 249.70
Low
SEKÂ 246.00
Mkt. cap
63.46B
Avg. vol.
570.26K
Volume
60.38K
Dividend
1.90%
Quarterly dividend
SEKÂ 1.19
Ex-dividend date
Apr 22, 2026
P/E ratio
25.43
52-wk high
SEKÂ 251.40
52-wk low
SEKÂ 175.90
EPS
SEKÂ 9.82
Shares outstanding
254.15M
No. of employees
12K
Open
SEKÂ 246.40
High
SEKÂ 249.70
Low
SEKÂ 246.00
Mkt. cap
63.46B
Avg. vol.
570.26K
Volume
60.38K
Dividend
1.90%
Quarterly dividend
SEKÂ 1.19
Ex-dividend date
Apr 22, 2026
P/E ratio
25.43
52-wk high
SEKÂ 251.40
52-wk low
SEKÂ 175.90
EPS
SEKÂ 9.82
Shares outstanding
254.15M
No. of employees
12K
News stories
From web sources and news partners
BigGo Finance
·
20 minutes ago
Warren Buffett's Singular Investment Advice: Own the S&P 500, but Patience Is the Price
The Standard (HK)
·
1 hour ago
Panmure Liberum forecasts S&P 500 falling to 5,000, warns bull run nearing end
Barron's
·
1 hour ago
What to Watch This Week
Simply Wall Street
·
1 hour ago
US Stock Market Today: S&P 500 Futures Climb As Cooler Wages Temper Inflation Concerns
Profile
Getinge AB is a publicly traded Swedish medical technology company. The company produces and distributes medical products and equipment for the healthcare and life sciences industries. The company is divided into three business areas: Life Science, Acute Care Therapies, and Surgical Workflows. The group employs approximately 12,000 people worldwide. The CEO of the company is Mattias Perjos, and the chairman of the board is Johan Malmquist. With a sales share of around 40%, the United States is by far the most important market for the company due to significantly higher prices and margins there. China and various Western European countries follow. Wikipedia
About Getinge publ AB